heparitin-sulfate and Carcinoma--Merkel-Cell

heparitin-sulfate has been researched along with Carcinoma--Merkel-Cell* in 2 studies

Other Studies

2 other study(ies) available for heparitin-sulfate and Carcinoma--Merkel-Cell

ArticleYear
Infectious Entry of Merkel Cell Polyomavirus.
    Journal of virology, 2019, 03-15, Volume: 93, Issue:6

    Merkel cell polyomavirus (MCPyV) is a small, nonenveloped tumor virus associated with an aggressive form of skin cancer, Merkel cell carcinoma (MCC). MCPyV infections are highly prevalent in the human population, with MCPyV virions being continuously shed from human skin. However, the precise host cell tropism(s) of MCPyV remains unclear: MCPyV is able to replicate within a subset of dermal fibroblasts, but MCPyV DNA has also been detected in a variety of other tissues. However, MCPyV appears different from other polyomaviruses, as it requires sulfated polysaccharides, such as heparan sulfates and/or chondroitin sulfates, for initial attachment. Like other polyomaviruses, MCPyV engages sialic acid as a (co)receptor. To explore the infectious entry process of MCPyV, we analyzed the cell biological determinants of MCPyV entry into A549 cells, a highly transducible lung carcinoma cell line, in comparison to well-studied simian virus 40 and a number of other viruses. Our results indicate that MCPyV enters cells via caveolar/lipid raft-mediated endocytosis but not macropinocytosis, clathrin-mediated endocytosis, or glycosphingolipid-enriched carriers. The viruses were internalized in small endocytic pits that led the virus to endosomes and from there to the endoplasmic reticulum (ER). Similar to other polyomaviruses, trafficking required microtubular transport, acidification of endosomes, and a functional redox environment. To our surprise, the virus was found to acquire a membrane envelope within endosomes, a phenomenon not reported for other viruses. Only minor amounts of viruses reached the ER, while the majority was retained in endosomal compartments, suggesting that endosome-to-ER trafficking is a bottleneck during infectious entry.

    Topics: A549 Cells; Antigens, Viral, Tumor; Carcinoma, Merkel Cell; Cell Line; Cell Line, Tumor; Cell Movement; Fibroblasts; HEK293 Cells; HeLa Cells; Heparitin Sulfate; Humans; Merkel cell polyomavirus; N-Acetylneuraminic Acid; Polyomavirus Infections; Skin; Skin Neoplasms; Tumor Virus Infections; Viral Tropism

2019
Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.
    PLoS pathogens, 2011, Volume: 7, Issue:7

    Merkel cell polyomavirus (MCV or MCPyV) appears to be a causal factor in the development of Merkel cell carcinoma, a rare but highly lethal form of skin cancer. Although recent reports indicate that MCV virions are commonly shed from apparently healthy human skin, the precise cellular tropism of the virus in healthy subjects remains unclear. To begin to explore this question, we set out to identify the cellular receptors or co-receptors required for the infectious entry of MCV. Although several previously studied polyomavirus species have been shown to bind to cell surface sialic acid residues associated with glycolipids or glycoproteins, we found that sialylated glycans are not required for initial attachment of MCV virions to cultured human cell lines. Instead, glycosaminoglycans (GAGs), such as heparan sulfate (HS) and chondroitin sulfate (CS), serve as initial attachment receptors during the MCV infectious entry process. Using cell lines deficient in GAG biosynthesis, we found that N-sulfated and/or 6-O-sulfated forms of HS mediate infectious entry of MCV reporter vectors, while CS appears to be dispensable. Intriguingly, although cell lines deficient in sialylated glycans readily bind MCV capsids, the cells are highly resistant to MCV reporter vector-mediated gene transduction. This suggests that sialylated glycans play a post-attachment role in the infectious entry process. Results observed using MCV reporter vectors were confirmed using a novel system for infectious propagation of native MCV virions. Taken together, the findings suggest a model in which MCV infectious entry occurs via initial cell binding mediated primarily by HS, followed by secondary interactions with a sialylated entry co-factor. The study should facilitate the development of inhibitors of MCV infection and help shed light on the infectious entry pathways and cellular tropism of the virus.

    Topics: Animals; Capsid; Carcinoma, Merkel Cell; CHO Cells; Chondroitin Sulfates; Cricetinae; Cricetulus; Heparitin Sulfate; Merkel cell polyomavirus; Models, Biological; N-Acetylneuraminic Acid; Skin; Viral Tropism; Virus Internalization

2011